A study looking at personalised prehabilitation for myeloid leukaemia and myelodysplastic syndrome (PROPEL)
This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.
Rhyl
Available
A trial looking at different combinations of treatment for newly diagnosed myeloma (RADAR, Myeloma XV)
This trial is looking at bone marrow samples to help work out the best treatment for myeloma.
A trial of giredestrant and Phesgo for breast cancer (heredERA)
This trial is looking at adding giredestrant to Phesgo to improve treatment for breast cancer.
A study looking at personalised treatment for early HER2 positive breast cancer (HER2-RADiCAL)
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
A trial of venetoclax with low dose cytarabine for acute myeloid leukaemia (VICTOR)
This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.
A trial looking at durvalumab and tremelimumab for kidney cancer (RAMPART)
This trial is looking at durvalumab and tremelimumab after having surgery to remove kidney cancer.
A trial comparing different treatments for prostate cancer that has spread (IP2 ATLANTA)
This trial is looking at treating the prostate gland as well as the area of the body to where the cancer has spread.
A study to improve the diagnosis of bladder cancer (BladderPath Study)
This study is comparing the usual way of diagnosing bladder cancer with a newer way using an MRI scan.
A trial looking at a drug called S 95005 with bevacizumab for bowel cancer (SOLSTICE)
This trial is for people with bowel cancer that has spread to other parts of the body (metastatic).
A study to find out whether a PET-CT scan can help to tell who needs to have rituximab or obinutuzumab after the initial treatment for lymphoma (PETReA)
This study is for people with follicular lymphoma who are going to have treatment that reaches their whole body (systemic treatment) for the first time.